Vernal Biosciences supplies high purity mRNA, from concept to the clinic.
Location: United States, Vermont, Colchester
Total raised: $21M
Investors 2
| Date | Name | Website |
| - | VCET Capit... | vcet.co |
| - | Alloy Ther... | alloytx.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.06.2022 | - | $21M | - |
Mentions in press and media 5
| Date | Title | Description |
| 29.06.2023 | Vernal Biosciences Announces an Additional $20MM in Funding to Expand GMP mRNA and LNP Manufacturing | Portfolio company Vernal Biosciences, an innovative mRNA and LNP Contract Development and Manufacturing Organization (“CDMO”) announced the completion of a $20MM funding round, led by Ampersand Capital Partners and Charles River Labs with p... |
| 07.02.2023 | Should I Invest In Biotech Stocks? | Biotech, short for biotechnology, is an industry responsible for making life-saving and life-changing drugs. The industry, having made a name for itself with the discovery of insulin, has helped the global population to live longer and heal... |
| 03.06.2022 | Vernal Biosciences Raises $21M in Funding | Vernal Biosciences, a Colchester, VT-based mRNA manufacturer and formulator of LNP-mRNA, closed a $21 million financing. The round was led by Ampersand Capital Partners and Dynamk Capital, with existing investors Alloy Therapeutics and ATUM... |
| 02.06.2022 | Dynamk Capital Co-Leads $21M Vernal Biosciences round along with Ampersand Capital Partners Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth | COLCHESTER, Vt., June 2, 2022 /PRNewswire/ -- Vernal Biosciences, a technology-leading mRNA manufacturer and formulator of LNP-mRNA, announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solut... |
| - | Vernal Biosciences | “Vernal Biosciences is an mRNA CDMO pioneering the custom mRNA development and manufacturing process for a variety of applications including vaccine development, gene replacement and more!” |